327 related articles for article (PubMed ID: 19205056)
1. Tricuspid regurgitant jet velocity elevation and its relationship to lung function in pediatric sickle cell disease.
Liem RI; Nevin MA; Prestridge A; Young LT; Thompson AA
Pediatr Pulmonol; 2009 Mar; 44(3):281-9. PubMed ID: 19205056
[TBL] [Abstract][Full Text] [Related]
2. Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension.
Liem RI; Young LT; Thompson AA
Haematologica; 2007 Nov; 92(11):1549-52. PubMed ID: 18024403
[TBL] [Abstract][Full Text] [Related]
3. Lower than expected elevated tricuspid regurgitant jet velocity in adults with sickle cell disease in Nigeria.
Musa BM; Odoh CN; Galadanci NA; Saidu H; Aliyu MH
Int Health; 2018 Sep; 10(5):356-362. PubMed ID: 29438485
[TBL] [Abstract][Full Text] [Related]
4. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.
Ambrusko SJ; Gunawardena S; Sakara A; Windsor B; Lanford L; Michelson P; Krishnamurti L
Pediatr Blood Cancer; 2006 Dec; 47(7):907-13. PubMed ID: 16496290
[TBL] [Abstract][Full Text] [Related]
5. Prolonged QTc interval in children and young adults with sickle cell disease at steady state.
Liem RI; Young LT; Thompson AA
Pediatr Blood Cancer; 2009 Jul; 52(7):842-6. PubMed ID: 19229972
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of tricuspid regurgitant jet velocity measurements in children and young adults with sickle cell disease undergoing screening for pulmonary hypertension.
Liem RI; Young LT; Lay AS; Pelligra SA; Labotka RJ; Thompson AA
Am J Hematol; 2010 Oct; 85(10):741-5. PubMed ID: 20652966
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease.
Pashankar FD; Carbonella J; Bazzy-Asaad A; Friedman A
Pediatrics; 2008 Apr; 121(4):777-82. PubMed ID: 18381543
[TBL] [Abstract][Full Text] [Related]
8. Elevated tricuspid regurgitant jet velocity, reduced forced expiratory volume in 1 second, and mortality in adults with sickle cell disease.
Chaturvedi S; Labib Ghafuri D; Kassim A; Rodeghier M; DeBaun MR
Am J Hematol; 2017 Feb; 92(2):125-130. PubMed ID: 27806442
[TBL] [Abstract][Full Text] [Related]
9. Proteinuria is associated with elevated tricuspid regurgitant jet velocity in children with sickle cell disease.
Forrest S; Kim A; Carbonella J; Pashankar F
Pediatr Blood Cancer; 2012 Jun; 58(6):937-40. PubMed ID: 21990235
[TBL] [Abstract][Full Text] [Related]
10. The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis.
Musa BM; Galadanci NA; Coker M; Bussell S; Aliyu MH
Ann Hematol; 2016 Oct; 95(11):1757-64. PubMed ID: 27181705
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary function correlates with body composition in Nigerian children and young adults with sickle cell disease.
VanderJagt DJ; Trujillo MR; Jalo I; Bode-Thomas F; Glew RH; Agaba P
J Trop Pediatr; 2008 Apr; 54(2):87-93. PubMed ID: 17901067
[TBL] [Abstract][Full Text] [Related]
12. The 6-min walk test: an independent correlate of elevated tricuspid regurgitant jet velocity in children and young adult sickle cell patients.
Agha H; El Tagui M; El Ghamrawy M; Abdel Hady M
Ann Hematol; 2014 Jul; 93(7):1131-8. PubMed ID: 24562420
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary function abnormalities in children with sickle cell disease.
Sylvester KP; Patey RA; Milligan P; Dick M; Rafferty GF; Rees D; Thein SL; Greenough A
Thorax; 2004 Jan; 59(1):67-70. PubMed ID: 14694252
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression.
Klings ES; Anton Bland D; Rosenman D; Princeton S; Odhiambo A; Li G; Bernard SA; Steinberg MH; Farber HW
Am J Hematol; 2008 Jul; 83(7):547-53. PubMed ID: 18383329
[TBL] [Abstract][Full Text] [Related]
15. A hemodynamic study of pulmonary hypertension in sickle cell disease.
Parent F; Bachir D; Inamo J; Lionnet F; Driss F; Loko G; Habibi A; Bennani S; Savale L; Adnot S; Maitre B; Yaïci A; Hajji L; O'Callaghan DS; Clerson P; Girot R; Galacteros F; Simonneau G
N Engl J Med; 2011 Jul; 365(1):44-53. PubMed ID: 21732836
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension of sickle cell disease: more than just another lung disease.
Klings ES
Am J Hematol; 2008 Jan; 83(1):4-5. PubMed ID: 17924550
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension in children with sickle cell disease.
Zuckerman WA; Rosenzweig EB
Expert Rev Respir Med; 2011 Apr; 5(2):233-43. PubMed ID: 21510733
[TBL] [Abstract][Full Text] [Related]
18. A prospective appraisal of pulmonary hypertension in children with sickle cell disease.
Sedrak A; Rao SP; Miller ST; Hekmat V; Rao M
J Pediatr Hematol Oncol; 2009 Feb; 31(2):97-100. PubMed ID: 19194191
[TBL] [Abstract][Full Text] [Related]
19. Lung function, haemoglobin and irreversibly sickled cells in sickle cell patients.
Jaja SI; Opesanwo O; Mojiminiyi FB; Kehinde MO
West Afr J Med; 2000; 19(3):225-9. PubMed ID: 11126090
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal changes in lung function and somatic growth in children with sickle cell disease.
Koumbourlis AC; Lee DJ; Lee A
Pediatr Pulmonol; 2007 Jun; 42(6):483-8. PubMed ID: 17469146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
